Exosome service pages are the one page type I tell regen clinics not to build. No exosome product is FDA approved. So a page that sells one is an offer for an unapproved product, and careful words do not change that. This post shows what to build instead: an exosome education page. It covers what the page may hold, what it may not, and how to handle patient questions.
TLDR: No exosome product is FDA approved for any use, and the FDA treats exosomes used to treat disease as drugs and biological products. So there is no compliant version of exosome service pages. Build an education page instead. Put the status first, then biology, the FDA’s sources and why the page makes no claims. Leave out any procedure, booking path, price or outcome. Good structure lowers claim risk, but it does not make an exosome service lawful. Whether to offer one at all is a call for your counsel.
Important Note This article is for educational purposes only and does not constitute legal, medical, or regulatory advice. Marketing strategies discussed should be reviewed by qualified legal counsel before implementation, particularly regarding FDA, FTC, and state-specific advertising regulations. Regen Portal is a marketing and consulting company, not a law firm.
Clinic owners ask me for an exosome page built like their PRP page. Same layout, same “what to expect” section, same button at the bottom. I get why. Patients ask about exosomes, and a service page feels like the next step.
Came here for an exosome service page template? Here is the short answer: there is no compliant one. What a clinic can build is an education page.
So this post shows you that page. You will see what goes on it, what stays off it, and what your team says when a patient asks about exosomes.
Why There Is No Compliant Exosome Service Page
A service page offers something. With exosomes, there is nothing approved to offer. No exosome product is FDA approved for any use, and the FDA treats exosomes used to treat disease as drugs and biological products.
You can read the FDA’s safety notification on exosome products yourself. It says exosomes used to treat diseases and conditions need premarket review and approval. A page that offers the product at your clinic markets an unapproved product, whatever the wording.
Good structure still matters. It lowers the risk that a claim slips onto the page. But structure does not make an exosome service lawful. Whether a clinic offers exosomes at all is a call for your counsel, not your web designer.
What this means for your practice: Stop asking how to write an exosome service page. Ask what an exosome education page can hold. Our breakdown of exosome marketing rules gives the wider view.
What an Exosome Education Page May Contain
An exosome education page teaches. It does not sell. Here is what it may hold, in this order. The status comes first, because every reader should see it before anything else.
The Status and a Disclaimer, at the Top
Open with the status sentence. Put it in the body, in normal type. Use these words: No exosome product is FDA approved for any use, and the FDA treats exosomes used to treat disease as drugs and biological products. Put the page disclaimer right next to it. A footer note alone does not do this job.
What Exosomes Are
Then the biology. Exosomes are extracellular vesicles, tiny particles that cells release. They carry proteins, lipids and RNA. Scientists study them to learn how cells signal to each other. Stop there. Do not say what they do for a patient.
How the FDA Regulates Them
Explain the rules in plain words. The FDA’s tissue and tissue products page shows how human cell and tissue products are grouped. Exosome products are not in the narrow group that skips premarket review. None is approved. Our explainer on the 361 versus 351 framework covers the test.
Why the Page Makes No Claims
Say why the page makes no claims. A line like “Because no exosome product is FDA approved, this page does not describe any treatment use” tells the reader what the page is. It also keeps your own team from adding claims later.
Links to the FDA’s Own Pages
Link to the FDA’s safety notification and its consumer alert on regen products. The compliance rules I follow treat links to FDA safety notices as clearly fine. Not much else about exosomes gets that rating. Our guide to the FDA stance on exosome products covers what those notices say.
What this means for your practice: If a section does not teach biology or status, it does not belong on the page.
What the Page May Not Contain
Everything that makes a page a service page stays off it. That includes the parts that feel harmless.
| Service Page Element | Why It Stays Off |
|---|---|
| A description of the procedure at your clinic | It describes a service built on an unapproved product |
| A book, schedule or consult button | It is a booking prompt for an unapproved product |
| A price, package or membership | It is an offer, and a price makes the offer concrete |
| Outcomes, timelines or a “what to expect” section | Each one is an implied efficacy claim |
| A list of conditions patients ask about | It ties the product to a disease |
| Patient testimonials | A treatment story is an implied efficacy claim, even with a disclosure |
| Soft verbs like “supports,” “promotes” or “may aid” | Out for exosome, cord and placental products since the FDA’s October 13, 2026 letter |
| “Research suggests” lines | Each one needs a data link, an evidence grade and an FDA line, and still points toward a benefit |
| Supplier white papers, viability studies or counts per vial | Posting them makes them your promotion |
| An exosome inquiry form | It is a booking path by another name |
What this means for your practice: If a reader can get from the page to an appointment, a price or a form, it is still a service page. For line-by-line swaps, use our exosome copy word list.
How to Handle Patient Questions About Exosomes
Patients will still ask. Some read about exosomes online. Some saw a competitor’s ad. Your team needs an answer ready. It should be one your counsel has cleared in writing.
Here is how I would set it up:
- Write one short answer and have counsel clear it. It restates the status sentence and points to the FDA’s notice.
- Use that same answer on the phone, at the front desk, in email, in DMs and in comment replies.
- Do not describe a procedure, quote a price or book an exosome visit from that answer.
- If your clinic takes part in an FDA-authorized clinical trial, counsel decides how staff talk about it.
- Log the questions. They show you what to teach on the education page.
Keep your website contact form general, not condition-based. That lowers your HIPAA exposure. A form that asks about a health condition can pull private data into your tools. Our post on HIPAA gaps in clinic funnels covers the rest.
Sometimes the question is “is it even legal?” Our post on whether exosomes are legal splits it into three parts.
What this means for your practice: The answer to an exosome question is the status. Say it the same way every time, in words counsel approved.
Where PRP Pages Differ
PRP pages work differently, and it helps to know why. PRP kits at least have a device clearance, for bone graft handling only, and every other use is off-label. A PRP page can describe the cleared device with off-label framing.
An exosome page has no approved product to describe. So the PRP service page model does not carry over. Our guide to PRP service page structure covers that model, for PRP only.
What this means for your practice: Do not clone your PRP page for exosomes. Start from the education page instead.
Check Your State Before the Page Goes Live
Federal status is the same in every state. But some states add notice laws on top. Florida, Utah, Tennessee, Vermont, Washington and Georgia require a set notice, word for word, in ads by practitioners who perform stem cell therapies.
Two of those laws reach past stem cells. Tennessee’s covers stem cell or regenerative medicine therapies. Vermont’s covers stem cell-related products. California and Wyoming have their own rules, and I would carry a notice there too.
Ask counsel whether your state’s notice belongs on an exosome education page. If it does, copy it word for word, at the type size the law requires. Our guide to stem cell and exosome laws by state covers each one.
What this means for your practice: The state check is a step on the page checklist, not an afterthought in the footer.
Picture a Practice Turning Its Service Page Into an Education Page
Picture a practice with an exosome page that has been live for a year. Here is how it might rebuild it.
The Challenge: The old page called the service exosome therapy that heals joints faster. It listed conditions by name and ended with a book now button. The status sat in small footer text, if it showed up at all.
The Approach: The team stops treating it as a service page. The procedure section, the condition list, the button and the prices come out. The status sentence moves to the top, next to the disclaimer.
The Compliance Check: What is left is biology, status and FDA links. A line explains why the page makes no claims. Staff get one counsel-cleared answer for patient questions. Counsel decides, in writing, whether the practice offers exosomes at all.
What Changed: The page now teaches and offers nothing. It has no path to an appointment, and the offer question sits with counsel.
Note: This scenario is illustrative and does not reference any specific Regen Portal client.
Frequently Asked Questions
Can I Build a Compliant Exosome Service Page?
No. A service page offers a product. And no exosome product is FDA approved for any use. Build an exosome education page instead. Leave the question of offering exosomes to your counsel.
Where Should the Exosome Status Go on the Page?
At the top, in the body, before anything else. Put the disclaimer right next to it. A status line in the footer does not do its job.
Can the Page Describe How Our Procedure Works?
No. A procedure description tells the reader you provide the product. That makes the page an offer. Keep the page to biology and status.
Can I Put Testimonials on an Exosome Page?
No. With no approved exosome product, a treatment story works as an implied efficacy claim. Testimonials on other pages need care too. If your practice is a covered entity, get the patient’s written HIPAA authorization first. Also follow the FTC’s endorsement guides. When a story is not typical, say clearly what results people can generally expect.
What Should Staff Say When a Patient Asks About Exosomes?
One short answer that counsel has cleared in writing. It restates that no exosome product is FDA approved and points to the FDA’s notice. It does not describe a procedure, quote a price or book a visit.
Does Good Page Structure Make Offering Exosomes Lawful?
No. Structure lowers the risk of a stray claim. It does not change the product’s status. Whether to offer exosomes is a legal call for counsel.
Does a State Notice Belong on an Exosome Education Page?
Ask counsel. Florida, Utah, Tennessee, Vermont, Washington and Georgia require a notice in stem cell ads. The Tennessee and Vermont laws reach past stem cells. If a notice applies, copy it word for word.
Key Takeaways
- There is no compliant exosome service page. Build an education page instead.
- No exosome product is FDA approved for any use, and the FDA treats exosomes used to treat disease as drugs and biological products.
- Put the status and a disclaimer at the top of the page, in the body.
- Teach the biology, link to the FDA, and say why the page makes no claims.
- Leave out any procedure, booking path, price, outcome, condition list or testimonial.
- Answer patient questions with one counsel-cleared line, the same way every time.
- Check your state’s notice law with counsel before the page goes live.
- Good structure lowers claim risk. It does not make an exosome service lawful.
Your Next Step
PS: If your site still has an exosome service page, send it to me and I’ll show you what an education page keeps and what it cuts. Reach out at hello@regenportal.com, or watch how we approach regen service page compliance on YouTube at https://www.youtube.com/@oatellez.
Compliance Disclaimer This article is educational and does not constitute legal, medical, or regulatory advice. It reflects publicly available information that can change as regulations, enforcement priorities, and platform policies evolve. It does not promise any marketing outcome or specific compliance result. Before acting on anything here, have your own marketing reviewed by qualified legal counsel familiar with FDA, FTC, HIPAA, and the advertising rules in your state.
About Regen Portal: Regen Portal is a marketing and consulting company built for the regenerative medicine industry. We handle practice consulting, marketing compliance, search engine optimization, content creation, social media management, paid advertising, website development, branding, and AI and ops consulting for clinics, manufacturers, distributors, and independent providers. For more on me and how we work, visit Regen Portal and contact us.
About Oscar Tellez: Oscar Tellez is the founder of Regen Portal, a marketing and consulting company built for the regenerative medicine industry. He has been in this industry since 2015. He started in medical sales and has worked with PRP since 2016. He has reached hundreds of practices and over 200 doctors through sales, teaching and marketing. He holds a B.S. in Exercise Science and Health Promotion from Florida Atlantic University.
